A comparison of topical diclofenac with prednisolone for postcataract inflammation

Arch Ophthalmol. 1995 Jun;113(6):725-7. doi: 10.1001/archopht.1995.01100060051031.

Abstract

Objective: To compare diclofenac sodium with prednisolone acetate for the control of postoperative inflammation after cataract surgery.

Design: Fifty-two patients undergoing phacoemulsification with posterior chamber intraocular lens implantation were randomly assigned to receive either 0.1% diclofenac eye drops or 1% prednisolone eye drops as their postoperative anti-inflammatory medication. The patients were examined 1 day (baseline), 1 week, and 1 month after surgery. Postoperative inflammation was evaluated subjectively by slit-lamp assessment of cell and flare and objectively by measurement of cell and flare with a laser cell and flare meter.

Results: At each visit, there was no statistically significant difference in postoperative inflammation either by slit-lamp assessment or with the laser cell and flare meter for the two treatment groups.

Conclusion: In the dosage used, diclofenac was as effective an anti-inflammatory agent for uncomplicated post-cataract inflammation as prednisolone.

Publication types

  • Clinical Trial
  • Comparative Study
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Administration, Topical
  • Anterior Chamber / pathology
  • Cataract Extraction*
  • Cell Count
  • Diclofenac / administration & dosage*
  • Double-Blind Method
  • Endophthalmitis / drug therapy
  • Endophthalmitis / etiology
  • Endophthalmitis / prevention & control*
  • Humans
  • Intraocular Pressure
  • Lenses, Intraocular
  • Ophthalmic Solutions
  • Postoperative Complications / prevention & control*
  • Prednisolone / administration & dosage*

Substances

  • Ophthalmic Solutions
  • Diclofenac
  • Prednisolone